STOCK TITAN

Deep Isolation Nuclear Q3 2026 loss widens to $3.76M

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Deep Isolation Nuclear, Inc. (DBHL) reported third-quarter 2026 revenue of $1.787 million, up 6% from $1.683 million in Q3 2025. Net loss widened to $3.764 million from $1.307 million. Selling, general and administrative expense rose 74% to $4.326 million, while research and development expense was $450,000 versus $0. The company attributed higher selling and administrative costs mainly to stock-based compensation and added employees; research and development spending related to long-lead items and engineering for its pilot.

Cash was $16.540 million at September 30, 2026, versus $27.434 million at December 31, 2025. Net cash used in operating activities for the nine months ended September 30, 2026 was $10.868 million, compared with $3.230 million a year earlier. Deep Isolation continued its non-radioactive, full-scale deep-borehole pilot near Cameron, Texas. After quarter-end, the Texas Railroad Commission issued a drilling permit on October 1, 2026, and well-pad construction began October 28, 2026; the permit does not authorize radioactive-waste disposal. The company was selected as sole industrial partner on three DOE Project GENESIS grants.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 2 points

How the balance works

Positive

  • Moderate pointQuarterly revenue increased 6% to $1.787 million year over year.

Negative

  • Moderate pointQuarterly net loss widened to $3.764 million from $1.307 million.
  • Moderate pointNine-month operating cash use rose to $10.868 million from $3.230 million.

Filing Explained

At September 30, 2026, 57,726,850 common shares were outstanding, versus 57,542,113 at December 31, 2025; 2026 equity records list option exercises and restricted-stock-unit distributions, and issuing additional shares reduces existing holders’ percentage ownership absent offsetting changes.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Revenue $1.787 million Three months ended September 30, 2026; $1.683 million in the year-earlier quarter; up 6%.
Net loss $3.764 million loss Three months ended September 30, 2026, compared with $1.307 million in Q3 2025.
Selling, general and administrative expense $4.326 million Three months ended September 30, 2026; up 74% from $2.493 million in Q3 2025.
Cash $16.540 million As of September 30, 2026, compared with $27.434 million as of December 31, 2025.
Net cash used in operating activities $10.868 million Nine months ended September 30, 2026, compared with $3.230 million in the same 2025 period.
EBITDA $3.819 million loss Three months ended September 30, 2026, compared with a $1.510 million loss in Q3 2025; non-GAAP measure.
Adjusted EBITDA $3.369 million loss Three months ended September 30, 2026, compared with a $1.410 million loss in Q3 2025; non-GAAP measure.
Research and development expense $450,000 Three months ended September 30, 2026.
deep borehole disposal technology technical
"full-scale, at-depth demonstration of its deep borehole disposal technology"
Universal Canister System technical
"full-scale emplacement and retrieval of the Company’s Universal Canister System"
Commercialization Pilot technical
"the Commercialization Pilot near Cameron, Texas"
non-GAAP financial measures financial
"EBITDA and Adjusted EBITDA are non-GAAP financial measures"
Non-GAAP financial measures are numbers companies use to show their financial performance that exclude certain expenses or income. They help investors see how the company might perform without one-time costs or other unusual items, giving a different perspective from official reports. However, since they can be adjusted, they don’t always tell the full story and should be looked at alongside standard financial figures.
Adjusted EBITDA financial
"Adjusted EBITDA is defined as EBITDA before certain items"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
Revenue $1.787 million Up 6% from $1.683 million in Q3 2025
Net loss $3.764 million loss Compared with $1.307 million loss in Q3 2025
Selling, general and administrative expense $4.326 million Up 74% from $2.493 million in Q3 2025
EBITDA $3.819 million loss Compared with $1.510 million loss in Q3 2025
Adjusted EBITDA $3.369 million loss Compared with $1.410 million loss in Q3 2025

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much revenue and what net loss did DBHL report for Q3 2026?

Deep Isolation reported $1.787 million in revenue for the three months ended September 30, 2026, up 6% from $1.683 million in the year-earlier quarter; net loss was $3.764 million versus $1.307 million.

What did Deep Isolation’s DOE-funded recycled-fuel waste study find?

The study projected that all disposal scenarios would cost less than the program target of 0.1 cent per kilowatt-hour of electricity generated, and all scenarios under expected conditions met the study’s safety performance criteria.

What are the focus areas of DBHL’s Project GENESIS grants?

Deep Isolation was selected as the sole industrial partner on three competitive Project GENESIS grants. Two projects are led by Lawrence Berkeley National Laboratory and one by the University of South Carolina; the work covers AI-enabled repository site screening, design and performance analysis.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001918080 0001918080 2026-11-12 2026-11-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 12, 2026

 

 

DEEP ISOLATION NUCLEAR, INC.

(Exact Name of Registrant as Specified in Charter)

 

Delaware

  000-56406   87-4225965

(State or Other Jurisdiction

of Incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

5717 Legacy Drive, Suite 250 Office 2079

Plano, Texas

  75024
(Address of Principal Executive Offices)   (Zip Code)

 

(509)-943-5222

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 2.02 Results of Operations and Financial Condition.

 

On November 12, 2026, Deep Isolation Nuclear, Inc., a Delaware corporation (the “Company”), issued a press release (the “Press Release”) announcing its financial results for the third quarter ended September 30, 2026.

 

A copy of the Press Release referenced above is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “1934 Act”), nor shall it be deemed “incorporated by reference” into any filing under the Securities Act of 1933, as amended, or the 1934 Act, except as may be expressly set forth by specific reference in such filing.

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit Number   Description
99.1   Press Release, dated November 12. 2026
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  DEEP ISOLATION NUCLEAR, INC.
     
Date: November 13, 2026 By: /s/ Rodney Baltzer
   

Rodney Baltzer

President and Chief Executive Officer

 

2

 

Exhibit 99.1

 

 

FOR IMMEDIATE RELEASE

 

Deep Isolation Nuclear, Inc. Reports Operational and Financial Results for the Third Quarter of 2026

 

Operational Highlights for the Third Quarter of 2026

 

●Common stock approved for quotation and began trading on the OTCQB Venture Market under the ticker symbol “DBHL” in July 2026

 

●Selected as the sole industrial partner on three U.S. Department of Energy (“DOE”) Project GENESIS grants advancing artificial intelligence-enabled nuclear waste repository analysis

 

●Announced results from a three-year DOE-funded study evaluating deep borehole disposal of waste generated by recycling used nuclear fuel

 

●Subsequent to quarter-end, published customer case study with Slovenia’s Agency for Radio Active Waste Management highlighting the potential cost and operational benefits of Deep Isolation’s deep borehole disposal approach

 

●Subsequent to quarter-end, announced receipt of a drilling permit from the Texas Railroad Commission for the Company’s full-scale, non-radioactive Commercialization Pilot near Cameron, Texas

 

●Subsequent to quarter-end, began site preparation, including well pad construction for the full-scale, non-radioactive Commercialization Pilot near Cameron, Texas

 

Financial Highlights for the Third Quarter of 2026

 

●Reported consolidated revenue of $1.8 million

 

●Reported research and development expense of approximately $0.5 million related to the non-radioactive, full-scale, at-depth demonstration of the Company’s deep borehole waste disposal technology

 

●Had available cash of $16.5 million as of September 30, 2026

 

●Reported a net loss of $3.8 million primarily attributable to research and development and selling, general, and administrative expenses

 

●Total common shares outstanding as of November 9, 2026 of 57,765,606

 

PLANO, TX, November 12, 2026 – Deep Isolation Nuclear, Inc. (OTCQB: DBHL) (“Deep Isolation” or the “Company”), a leading innovator in nuclear waste disposal technology, today announced its operational and financial results for the three months ended September 30, 2026.

 

“The third quarter advanced our work toward commercial readiness,” said Rod Baltzer, CEO of Deep Isolation. “We announced results from a three-year DOE-funded study evaluating a permanent disposal pathway for waste from recycled nuclear fuel, and we continued to advance our full-scale, non-radioactive Commercialization Pilot near Cameron, Texas. Subsequent to quarter-end, receipt of the drilling permit from the Texas Railroad Commission and the start of well pad construction marked further steps toward field execution.

 

“Additionally, our common stock began trading on the OTCQB Venture Market in July, and we were selected as the sole industrial partner on three DOE Project GENESIS grants focused on artificial intelligence-enabled repository analysis. We believe the industry’s growing attention to the full nuclear fuel cycle reinforces the importance of developing practical permanent nuclear waste disposal solutions. Our focus remains on demonstrating our technology and working with customers and collaborators to advance its commercial adoption.”

 

 

 

 

Operational Progress

 

During the third quarter, Deep Isolation continued engineering and procurement activities for its non-radioactive, full-scale, at-depth demonstration of its deep borehole disposal technology (the “Commercialization Pilot”) at the Deep Borehole Demonstration Center (“DBDC”), located at Halliburton’s Drilling Technology Facility near Cameron, Texas. The program is designed to test borehole construction, surface handling, and full-scale emplacement and retrieval of the Company’s Universal Canister System (“UCS”). Subsequent to quarter-end, on October 1, 2026, the Company announced that the Texas Railroad Commission had issued a drilling permit, allowing the project to advance toward construction and field activities. The permit is for the non-radioactive pilot and does not authorize disposal of radioactive waste.

 

On October 28, 2026, the Company announced that site preparation, including well pad construction, had begun at the DBDC. The pad will support drilling, casing and cementing operations for the demonstration borehole as part of the Commercialization Pilot. The Commercialization Pilot is being conducted in collaboration with the DBDC, Halliburton, Amentum, NAC International and Occlusion Nuclear Solutions, using non-radioactive packages to simulate repository operations.

 

Commercial Progress and Other Company Events

 

In July 2026, the Company’s common stock was approved for quotation on the OTCQB Venture Market under the symbol “DBHL.” On July 23, 2026, Deep Isolation was selected as the sole industrial partner on three competitive grants under DOE’s Project GENESIS program. Two projects are led by Lawrence Berkeley National Laboratory and one by the University of South Carolina, advancing artificial intelligence-enabled repository site screening, design and performance analysis.

 

On September 22, 2026, Deep Isolation announced results from a three-year DOE-funded project under ARPA-E’s CURIE program, conducted with Argonne National Laboratory, Oklo and Case Western Reserve University. Deep Isolation evaluated packaging, repository design, long-term safety and economics for disposal of waste from recycled nuclear fuel. All disposal scenarios studied were projected to cost less than the program’s target of 0.1 cent per kilowatt-hour of electricity generated, and all scenarios under expected conditions met the study’s safety performance criteria.

 

Subsequent to quarter-end, on October 14, 2026, the Company published a customer case study featuring Slovenia’s Agency for Radioactive Waste Management. The assessment compared a standalone disposal facility for TRIGA II research-reactor spent fuel with integration into a proposed deep borehole repository for Krško Nuclear Power Plant spent fuel. The analysis found that integrating the smaller inventory could increase total repository lifecycle costs by less than approximately 0.5%, illustrating the potential benefits of shared disposal infrastructure.

 

Nuclear Industry Developments

 

Permanent nuclear waste disposal remained central to discussions of a sustainable nuclear fuel cycle during the third quarter and subsequent to quarter-end. In the United States, the Department of Energy continued exploring Nuclear Lifecycle Innovation Campuses through voluntary federal-state partnerships that could co-locate enrichment, fuel fabrication, used-fuel reprocessing and waste disposition. Utah, Tennessee, Oklahoma, Louisiana and Idaho signed memoranda of understanding in July. These agreements represent continued exploration of potential host sites, rather than authorization to construct or operate a repository. The initiative highlights the importance of considering permanent disposal alongside investment in nuclear generation and fuel recycling.

 

Internationally, Finland advanced toward permanent nuclear waste disposal in a mined repository when its nuclear safety regulator issued a favorable safety assessment in August. Subsequent to quarter-end, on October 22, the Finnish Government granted Posiva an operating license for its spent-fuel encapsulation and final disposal facility at Olkiluoto, the first such license for a mined repository worldwide. Commissioning tests, inspections and regulatory approvals remain necessary before production operations begin. Fuel-cycle innovation also continued in the United States: in October, ARPA-E selected eight projects for award negotiations under its HORNIG program focused on advanced reactor fuels and the use of recycled nuclear materials. In management’s view, recycling and permanent disposal are complementary elements of long-term waste management, including disposal of the residual waste generated by recycling.

 

Broader nuclear investment continued to reflect demand for reliable electricity, including from artificial intelligence and data centers. Subsequent to quarter-end, Google and Constellation announced a 20-year power purchase agreement on October 6 intended to enable 890 megawatts of additional nuclear capacity through upgrades at 11 existing reactor units. Such investments illustrate the role of existing nuclear facilities in meeting growing power demand while advanced reactor technologies progress toward deployment. In management’s view, continued operation of existing reactors, new nuclear capacity and investment in fuel recycling could expand the long-term need for permanent disposal solutions. Realizing that opportunity will depend on successful technology demonstration, licensing, financing, community engagement and, in the United States, legislative changes needed to allow commercialization of deep borehole disposal.

 

2

 

 

Financial Summary

 

   For the Three Months Ended 
(Amounts in thousands)  9/30/2026   9/30/2025 
Revenue  $1,787   $1,683 
Research and development expense   450    — 
Selling, general and administrative expenses   4,326    2,493 
Net Loss   (3,764)   (1,307)
EBITDA1   (3,819)   (1,510)
Adjusted EBITDA1   (3,369)   (1,410)
Cash (as of)   16,540    28,209 

 

Revenue increased by approximately $0.1 million, or 6%, for the three months ended September 30, 2026, compared to the three months ended September 30, 2025. The increase in revenue was primarily attributable to completion milestones achieved for certain projects at Deep Isolation along with increased billing at existing projects at Freestone Environmental Services, Inc. (“Freestone”), the Company’s wholly owned environmental consulting subsidiary.

 

Research and development expense increased by approximately $0.5 million for the three months ended September 30, 2026, compared to the three months ended September 30, 2025. The increase in research and development expense was attributed to the ordering of long-lead items and front-end engineering work related to the Company’s non-radioactive, full-scale, at-depth demonstration of its deep borehole disposal technologies.

 

Selling, general and administrative expenses increased by approximately $1.8 million, or 74%, for the three months ended September 30, 2026, compared to the three months ended September 30, 2025. The increase in selling, general and administrative expenses was primarily attributable to stock-based compensation along with higher employee and benefits expenses following the addition of 9 new employees since the beginning of 2026, including the Chief Financial Officer and General Counsel.

 

Net loss increased by $2.5 million for the three months ended September 30, 2026, compared to the three months ended September 30, 2025, primarily due to the increases in research and development and selling, general and administrative expenses described above.

 

EBITDA1 was a loss of 3.8 million for the three months ended September 30, 2026, compared to a loss of 1.5 million for the three months ended September 30, 2025. The decrease in EBITDA was primarily attributed to higher research and development expenses and selling, general, and administrative expenses as described above.

 

Adjusted EBITDA1 was a loss of $3.4 million for the three months ended September 30, 2026, compared to $1.4 million for the three months ended September 30, 2025. The decrease in Adjusted EBITDA was primarily attributed to higher selling, general, and administrative expenses as described above.

 

About Deep Isolation

 

Deep Isolation (OTCQB: DBHL) is the first company to undertake development of technologies for nuclear waste disposal in deep boreholes. Deep Isolation’s solution is designed to offer a unique approach to help countries identify, plan for and complete the necessary steps to dispose of their nuclear waste inventories. With over 100 patents issued to date, Deep Isolation’s technology is designed to leverage proven drilling practices to allow safe isolation of waste deep underground in horizontal, vertical, or slanted borehole repositories. Deep Isolation’s Universal Canister System is engineered to support integrated management of spent fuel and high-level radioactive waste from legacy and advanced reactors across storage, transportation, and eventual disposal. In January 2026, Deep Isolation launched a full-scale, at-depth deep borehole Commercialization Pilot for its solution at Cameron, Texas, in collaboration with the Deep Borehole Demonstration Center, Halliburton (NYSE: HAL), Amentum (NYSE: AMTM), NAC International (TYO: 7004), and Occlusion Nuclear Solutions.

 

 

1 EBITDA and Adjusted EBITDA are non-GAAP financial measures and should not be used in isolation or as a substitute for Deep Isolation’s financial results presented in accordance with Generally Accepted Accounting Principles (“GAAP”). For the definitions and reconciliations of these measures to the most directly comparable financial measures calculated and presented in accordance with GAAP, please refer to Exhibit II at the end of this press release

 

3

 

 

For more information, visit: deepisolation.com

 

Media Contact:

 

Sophie McCallum

media@deepisolation.com

 

Investor Contact:

 

Caldwell Bailey

ICR, Inc.

InvestorRelations@deepisolation.com

 

Forward-Looking Statements

 

Statements contained in this press release that are not historical facts are “forward-looking information” or “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, but are not limited to, statements regarding our plans, objectives and expectations for our business, the future growth of our business and the nuclear energy and nuclear waste disposal industries as a whole, the Commercialization Pilot, and future benefits expected to arise from our strategic partnerships. In certain cases, forward-looking statements can be identified by the use of words and phrases or variations of words and phrases or statements such as “may,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “will,” “could,” “project,” “target,” “potential,” “continue” and similar expressions. Forward-looking statements are based on management’s belief and assumptions, including current expectations and projections about future events and trends, and on information currently available to management.

 

Forward-looking statements in this or any other news release are subject to a number of risks, uncertainties, and assumptions that could cause actual results to be materially different from those expressed or implied by such forward-looking statements. Such risks, uncertainties, and assumptions are subject to a number of factors, including, among others: the failure of a market to develop for our deep borehole disposal solutions as quickly as we expect or at all; a failure of demand for our solution to develop sufficiently; regulatory and legal developments, including issues relating to obtaining regulatory approvals or permissions on the timelines we expect or at all; our lack of profitability; delays or failure in our initiative to complete a full-scale, at-depth demonstration of our Universal Canister System and our deep borehole solution; our failure to enter into contracts with customers or, once we do enter into contracts, to continue such contractual relationships or to receive new contract awards; our dependency on governmental contracts and awards and our ability to finalize negotiations on same; our failure to manage our growth effectively or to execute our business plan; our failure to sustain and expand relationships with governmental entities and strategic partners; a failure in the assumptions or analyses we have used in supporting forecasts or plans; our inability to commercialize our products at scale; the development or deployment of other technologies or solutions supplanting or competing with our technologies; challenges to our intellectual property; failures to protect, maintain, enforce, and enhance our intellectual property, and claims by others of intellectual property infringement; political and public perceptions of nuclear energy, including perceptions as to accidents or other high-profile events involving nuclear power facilities or radioactive materials; our liquidity and ability to raise capital; any inability to control operating and project costs and project delays or other project-related problems; security (including cybersecurity) breaches or disruptions; geopolitical, macroeconomic, domestic events or crises, including supply chain disruptions and other risks and uncertainties outside of our control; weather and effects of climate change; and litigation or legal proceedings that may be brought against us.

 

The foregoing is not an exhaustive list of all the factors that may cause any forward-looking statements to prove inaccurate or our actual results to differ materially from our expectations and forecasts. Moreover, we operate in a highly regulated environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties, and assumptions, the future events and trends discussed in this release may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements, and we cannot guarantee future results, performance, or achievements. Accordingly, readers should not place undue reliance on forward-looking statements. We undertake no obligation to update any forward-looking statements for any reason after the date of this press release or to conform these statements to actual results or revised expectations, except as required by law. Additional information concerning the factors above and other factors will be found in the Company’s public filings with the Securities and Exchange Commission (the “SEC”), including the sections titled “Forward-Looking Statements” and “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed with the SEC on March 30, 2026, its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2026 and June 30, 2026, filed with the SEC on May 15, 2026 and August 7, 2026, respectively, our Registration Statement Form S-1, originally filed August 18, 2025 and subsequently amended, our Proxy Statement for our 2026 Annual Meeting of Stockholders as filed on April 29, 2026, and in filings with the SEC that will be made in the future.

 

The Company’s SEC filings are available free of charge at www.sec.gov or upon written request to Deep Isolation at InvestorRelations@deepisolation.com or CorpSec@deepisolation.com.

4

 

 

Exhibit I - Unaudited Interim Financial Information

 

Deep Isolation Nuclear, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(in thousands, except share and per share data)

 

   September 30,
2026
(Unaudited)
  December 31,
2025
Assets      
Current assets:      
Cash  $16,540   $27,434 
Accounts receivable, net of allowance for credit losses of $135 and $118, respectively   769    439 
Contract assets   873    275 
Other current assets   836    672 
Total current assets   19,018    28,820 
           
Property, plant and equipment, net   193    128 
Intangible assets, net   13    73 
Finance lease right-of-use assets   9    11 
Operating lease right-of-use assets   178    269 
Goodwill   182    182 
Other non-current assets  $72   $140 
Total assets  $19,665   $29,623 
           
Liabilities and Stockholders’ Equity          
Current liabilities:          
Accounts payable  $749   $1,113 
Accrued payroll   316    774 
Contract liabilities   225    150 
Finance lease liabilities, current   3    3 
Operating lease liabilities, current   136    125 
Other current liabilities   390    101 
Total current liabilities   1,819    2,266 
           
Finance lease liabilities, net of current portion   6    9 
Operating lease liabilities, net of current portion   48    152 
Total liabilities   1,873    2,427 
Commitments and Contingencies (Note 16)          
Stockholders’ Equity          
Common stock, par value $0.0001 per share, 300,000,000 shares authorized, 57,726,850 and 57,542,113 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively   6    6 
Additional paid-in capital   62,244    59,456 
Accumulated deficit   (44,719)   (32,503)
Accumulated other comprehensive income   261    237 
Total stockholders’ equity   17,792    27,196 
Total liabilities and stockholders’ equity  $19,665   $29,623 

 

5

 

 

Deep Isolation Nuclear, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Unaudited) (in thousands, except share and per share data)

 

  

Three Months Ended

September 30,

 

Nine Months Ended

September 30,

   2026  2025  2026  2025
             
Revenue  $1,787   $1,683   $4,553   $4,837 
Cost of services  (exclusive of depreciation shown separately below)   (830)   (700)   (2,123)   (2,118)
Gross profit   957    983    2,430    2,719 
                     
Operating expenses:                    
Selling, general and administrative expenses   4,326    2,493    9,912    5,701 
Research and development   450    —    5,119    — 
Depreciation and amortization expense   36    29    86    88 
Total operating expenses   4,812    2,522    15,117    5,789 
                     
Loss from operations   (3,855)   (1,539)   (12,687)   (3,070)
                     
Gain on insurance settlement   —    —    27    — 
Other income   91    232    444    235 
Net loss before income taxes   (3,764)   (1,307)   (12,216)   (2,835)
                     
Provision for income taxes   —    —    —      1 
Net loss  $(3,764)  $(1,307)  $(12,216)  $(2,836)
                     
Other comprehensive income (loss):                    
Foreign currency translation adjustments   (9)   160    24    120 
Total other comprehensive income (loss)   (9)   160    24    120 
Net loss and other comprehensive loss  $(3,773)  $(1,147)  $(12,192)  $(2,716)
                     
Net loss per common share – basic and diluted  $(0.07)  $(0.02)  $(0.21)  $(0.06)
Weighted average common shares outstanding - basic and diluted   57,691,306    54,260,091    57,660,360    45,750,667 

 

6

 

 

Deep Isolation Nuclear, Inc. and Subsidiaries

Condensed Consolidated Statements of Changes in Stockholders’ Equity

(Unaudited) (in thousands, except share and per share data)

 

   Common Stock  

Preferred Stock

Series A

  

Preferred Stock Series A Prime

  

Additional

Paid in

   Accumulated  

Accumulated

Other

Comprehensive

  

Total

Stockholders’

 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Income   Equity 
Balance, January 1, 2025   773,941   $—    655,351   $—    115,057   $—   $29,962   $(27,167)  $122   $2,917 
Retroactive application of Merger   39,127,838    4    (655,351)   —    (115,057)   —    (4)   —    —    — 
Adjusted Balance beginning of quarter   39,901,779   $4    —   $—    —   $—   $29,958   $(27,167)  $122   $2,917 
Exercise of stock options   1,330,620    —    —    —    —    —    70    —    —    70 
Stock based compensation   —    —    —    —    —    —    25    —    —    25 
Foreign currency translation adjustments   —    —    —    —    —    —    —    —    (50)   (50)
Net loss   —    —    —    —    —    —    —    (166)   —    (166)
Balance, March 31, 2025   41,232,399    4    —    —    —    —    30,053    (27,333)   72    2,796 
                                                   
Exercise of stock options   2,737,355    —    —    —    —    —    324    —    —    324 
Stock based compensation   —    —    —    —    —    —    30    —    —    30 
Foreign currency translation adjustments   —    —    —    —    —    —    —    —    10    10 
Net loss   —    —    —    —    —    —    —    (1,363)   —    (1,363)
Balance, June 30, 2025   43,969,754    4    —    —    —    —    30,407    (28,696)   82    1,797 
                                                   
Exercise of stock options   304,545    —    —    —    —    —    40    —    —    40 
Stock based compensation   —    —    —    —    —    —    192    —    —    192 
Shares issued in reverse acquisition   2,250,000    —    —    —    —    —    (176)   —    —    (176)
Treasury Stock   (26,870)   —    —    —    —    —    (81)   —    —    (81)
Shares issued in private placement offering, net of offering costs   11,012,387    1    —    —    —    —    28,847    —    —    28,848 
Foreign currency translation   —    —    —    —    —    —    —    —    160    160 
Net loss   —    —    —    —    —    —    —    (1,307)   —    (1,307)
Balance, September 30, 2025   57,509,816   $5    —   $—    —   $—   $59,229   $(30,003)  $242   $29,473 

 

7

 

 

Deep Isolation Nuclear, Inc. and Subsidiaries

Condensed Consolidated Statements of Changes in Stockholders’ Equity

(Unaudited) (in thousands, except share and per share data)

 

   Common Stock  

Preferred Stock

Series A

  

Preferred Stock

Series A Prime

  

Additional

Paid in

   Accumulated  

Accumulated

Other

Comprehensive

  

Total

Stockholders’

 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Income   Equity 
Balance, January 1, 2026   57,542,113   $6    —   $—    —   $—   $59,456   $(32,503)  $237   $27,196 
Exercise of stock options and distribution of restricted stock units   105,500    —    —    —    —    —    4    —    —    4 
Stock based compensation   —    —    —    —    —    —    522    —    —    522 
Foreign currency translation adjustments   —    —    —    —    —    —    —    —    48    48 
Net loss   —    —    —    —    —    —    —    (5,416)   —    (5,416)
Balance, March 31, 2026   57,647,613    6    —    —    —    —    59,982    (37,919)   285   $22,354 
                                                   
Exercise of stock options and distribution of restricted stock units   19,500    —    —    —    —    —    —    —    —    — 
Stock based compensation   —    —    —    —    —    —    363    —    —    363 
Foreign currency translation adjustments   —    —    —    —    —    —    —    —    (15)   (15)
Net loss   —    —    —    —    —    —    —    (3,036)   —    (3,036)
Balance, June 30, 2026   57,667,113    6    —    —    —    —    60,345    (40,955)   270    19,666 
                                                   
Exercise of stock options and distribution of restricted stock units   59,737    —    —    —    —    —    11    —    —    11 
Stock based compensation   —    —    —    —    —    —    1,888    —    —    1,888 
Foreign currency translation   —    —    —    —    —    —    —    —    (9)   (9)
Net loss   —    —    —    —    —    —    —    (3,764)   —    (3,764)
Balance, September 30, 2026   57,726,850   $6    —   $—    —   $—   $62,244   $(44,719)  $261   $17,792 

 

8

 

 

Deep Isolation Nuclear, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited) (in thousands, except share and per share data

 

  

Nine Months Ended

September 30,

 
   2026   2025 
Cash Flows from Operating Activities:        
Net loss  $(12,216)  $(2,836)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization expense   86    88 
Interest expense   1    1 
Stock based compensation   2,773    247 
Gain on debt extinguishment   —    (74)
Gain on insurance settlement   (27)   — 
Changes in operating assets and liabilities:          
Accounts receivable   (347)   (499)
Allowance for credit losses   17    (17)
Contract assets   (598)   (30)
Other current assets   (164)   (968)
Other non current assets   68    — 
Accounts payable   (364)   605 
Contract liabilities   75    414 
Accrued expenses   (458)   (174)
Other current liabilities   289    16 
Operating lease right-of-use assets and lease liabilities   (3)   (3)
Net cash used in operating activities   (10,868)   (3,230)
Cash Flows from Investing Activities:          
Purchases of property, plant and equipment   (89)   (38)
Proceeds from insurance on disposal of fixed asset   27    — 
Cash acquired in reverse acquisition   —    7 
Net cash used in investing activities   (62)   (31)
Cash Flows from Financing Activities:          
Payment of finance lease liability   (3)   — 
Proceeds from issuance of Series A Prime Preferred Stock   —    — 
Proceeds from Offering, net of Offering costs   —    28,848 
Payment of share repurchase liability   —    (81)
Proceeds from exercise of stock options   15    434 
Net cash provided by financing activities   12    29,201 
           
Net change in cash and cash equivalents   (10,918)   25,940 
Effect of exchange rate on cash and cash equivalents   24    120 
           
Cash and cash equivalents:          
Beginning of period   27,434    2,149 
End of period  $16,540   $28,209 
           
Supplemental schedule of non-cash investing and financing activities:          
Issuance of common stock in reverse acquisition  $—   $176 

 

 

9

 

 

Exhibit II Non-GAAP Financial Measures: EBITDA and Adjusted EBITDA

 

EBITDA is defined as earnings before depreciation, amortization, finance income and expense, and taxes. Adjusted EBITDA is defined as EBITDA before certain items, including registration statement expenses and research and development expenses, that management believes are not indicative of core ongoing operations for the periods presented. EBITDA and Adjusted EBITDA are non-GAAP financial measures that are used as supplemental financial measures by management and external users of financial statements, such as investors, to assess our financial and operating performance. We believe that these non-GAAP financial measures assist our management and investors by increasing the comparability of our performance from period to period. We believe that including EBITDA and Adjusted EBITDA assists our management and investors in (i) understanding and analyzing the results of our operating and business performance, (ii) selecting between investing in us and other investment alternatives and (iii) monitoring our ongoing financial and operational strength in assessing whether to purchase and/or to continue to hold our common shares. This is achieved by excluding the potentially disparate effects between periods of, in the case of EBITDA and Adjusted EBITDA, financial income and expenses,, taxes, depreciation and amortization; in the case of Adjusted EBITDA, registration statement expenses and research and development expenses, which are excluded because they relate to specific, discrete initiatives and may vary significantly based on the timing and scope of such activities.

 

EBITDA and Adjusted EBITDA have limitations as analytical tools and should not be considered as alternatives to, or as substitutes for, or superior to, profit or loss, profit or loss from operations, earnings or loss per share or any other measure of operating performance presented in accordance with GAAP. Some of these limitations include the fact that they do not reflect (i) our cash expenditures or future requirements for capital expenditures or contractual commitments and (ii) changes in, or cash requirements for, our working capital needs. Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will have to be replaced in the future, and EBITDA and Adjusted EBITDA do not reflect any cash requirements for such replacements. EBITDA and Adjusted EBITDA are not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows and other companies in our industry may calculate these measures differently than we do, limiting their usefulness as a comparative measure.

 

In evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses that are the same as, or similar to, some of the adjustments in this presentation. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by the excluded items. Therefore, the non-GAAP financial measures as presented below may not be comparable to similarly titled measures of other companies in the nuclear or other industries.

 

The following table presents a reconciliation of net loss to EBITDA and Adjusted EBITDA for each of the periods presented (in thousands):

 

   For the Three Months Ended 
   September 30,
2026
   September 30,
2025
 
Net loss  $(3,764)  $(1,307)
Depreciation and amortization expense   36    29 
Other income (expense)   (91)   (232)
Provision for income taxes   —    — 
EBITDA   (3,819)   (1,510)
Registration statement expenses (1)   —    100 
Research and development expenses (2)   450    — 
Adjusted EBITDA  $(3,369)  $(1,410)

 

(1)Represents specific costs that are incremental and discrete to the periods presented and are not indicative of our core ongoing operations. For the three months ended September 30, 2025, these amounts were comprised of non-routine legal costs associated with the Company’s registration statement that do not qualify for equity issuance costs and outside the ordinary course of business.
(2)For the three months ended September 30, 2026, these amounts were comprised of research and development costs incurred to design, develop, test, and validate the Company’s technologies and services for the deep borehole disposal of nuclear waste. The Company believes excluding these investments provides investors with additional insight into the operating performance of its core business activities and enhances comparability across reporting periods by removing costs that may vary significantly based on the timing and scope of development initiatives.

 

10

 

Filing Exhibits & Attachments

4 documents

Keep reading